SCHEMBL25082131

SCHEMBL25082131

Cc1nc(-c2ccc(N3C[C@@H](C)O[C@@H](C)C3)nc2)nc2cc(F)ccc12

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TLR9 Q9NR96 1/20 0.47
▸ TLR8 Q9NR97 1/20 0.47
▸ TLR7 Q9NYK1 1/20 0.47
▸ ACVR1 Q04771 1/20 0.44
▸ AOC3 Q16853 3/20 0.44
▸ KDM4E B2RXH2 3/20 0.42
▸ ALDH1A1 P00352 3/20 0.42
▸ GAA P10253 1/20 0.42
▸ TSHR P16473 1/20 0.41
▸ MAPK1 P28482 1/20 0.41
▸ HSD17B10 Q99714 1/20 0.41
▸ HPGD P15428 2/20 0.41
▸ HTT P42858 1/20 0.41
▸ NPSR1 Q6W5P4 1/20 0.41
▸ TDP1 Q9NUW8 1/20 0.41
▸ MAP3K7 O43318 4/20 0.40
▸ GAK O14976 1/20 0.39
▸ CYP1A2 P05177 1/20 0.39
▸ CYP3A4 P08684 1/20 0.39
▸ CYP2C9 P11712 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25082159 0.88 SYK (0.45) ACVR1AOC3MAP3K7GAKWDR5
SCHEMBL25082096 0.85 TSHR (0.58) TLR9TLR8TLR7ACVR1AOC3
SCHEMBL25082179 0.83 TDO2 (0.54) AOC3
SCHEMBL25082092 0.82 TDO2 (0.43) AOC3
SCHEMBL25082139 0.80 TDO2 (0.41) AOC3
SCHEMBL25082145 0.80 TDO2 (0.41) TLR9TLR8TLR7AOC3ALDH1A1
SCHEMBL25082415 0.80 TDO2 (0.43) AOC3
SCHEMBL25082389 0.80 TDO2 (0.41) ACVR1AOC3KDM4E
SCHEMBL25082164 0.79 TDO2 (0.41) ACVR1AOC3ALDH1A1CYP3A4CYP2C9
SCHEMBL30249544 0.79 TDO2 (0.41) ACVR1AOC3ALDH1A1CYP3A4CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023020512-A1 SUBSTITUTED PYRIDINE ANALOGUE, PREPARATION METHOD THEREFOR, AND USE THEREOF AS AHR MODULATOR 成都奥睿药业有限公司 2023-02-23 — — WO disclosed
Send feedback